B cell lymphoma in HIV transgenic mice

Area of Science:

• Oncology
• Virology
• Immunology

Background:

• Human Immunodeficiency Virus Type I (HIV-1) infection is linked to a high incidence of B-cell lymphomas.
• The precise role of HIV in lymphomagenesis remains unclear, and effective in vivo models are lacking.
• Transgenic (Tg) 26 mice carrying a modified HIV-1 provirus spontaneously develop lymphoma.

Purpose of the Study:

• To characterize the phenotypic and molecular features of B-cell leukemia/lymphoma in HIV-1 Tg mice.
• To investigate the potential role of HIV proteins and cytokines in lymphoma development.
• To establish a relevant animal model for studying AIDS-related lymphomagenesis.

Main Methods:

• Analysis of transformed B cell populations in Tg mice.
• Assessment of cellular oncogene expression.
• Quantification of cytokine and HIV protein levels in lymphoma-bearing mice.

Main Results:

• The transformed B cells were identified as CD19+pre-BCR+CD127+CD43+CD93+ precursor B cells.
• Tumor cells exhibited clonal characteristics and increased expression of cellular oncogenes.
• Elevated levels of B-cell stimulatory cytokines (IL-1β, IL-6, IL-10, IL-12p40, IL-13, TNFα) and HIV proteins (p17, gp120, nef) were observed.

Conclusions:

• Elevated HIV proteins and B-cell stimulatory factors likely contribute to lymphoma development.
• The lymphomas in Tg mice closely resemble those in HIV/AIDS+ patients.
• This model offers a valuable tool for understanding AIDS-related lymphomagenesis and the role of HIV-1.